Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')

被引：81
|
作者：
Ricaurte, GA
McCann, UD
Szabo, Z
Scheffel, U
机构：
[1] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21224 USA
[2] Johns Hopkins Med Inst, Dept Psychiat, Baltimore, MD 21224 USA
[3] Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD 21224 USA
来源：
TOXICOLOGY LETTERS | 2000年 / 112卷
关键词：
serotonin; neurotoxicity; amphetamines; PET; transporters; 3,4-methylenedioxy-methamphetamine;
D O I：
10.1016/S0378-4274(99)00216-7
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
The recreational drug, (+/-)3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), is a potent serotonin (5-HT) neurotoxin in animals. Whether humans who use MDMA incur 5-HT neural injury is unknown. The present studies utilized positron emission tomography (PET) in conjunction with the 5-HT transporter ligand, [C-11]McN-5652 to assess the status of brain 5-HT neurons in human MDMA users. Like nonhuman primates treated with neurotoxic doses of MDMA, humans with a history of MDMA use showed lasting decrements in global brain [C-11]McN-5652 binding, with decreases in [C-11]McN-5652 binding positively correlated to the extent of previous MDMA use. These results suggest that human MDMA use results in brain 5-HT neurotoxicity. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：143 / 146
页数：4
相关论文
共 50 条
  • [1] Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
    Parrott, AC
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (01) : 71 - 83
  • [2] Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA)
    Morimoto, BH
    Lovell, S
    Kahr, B
    [J]. ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 : 229 - 231
  • [3] A review on the mitochondrial toxicity of "ecstasy" (3,4-methylenedioxymethamphetamine, MDMA)
    Capela, Joao Paulo
    Carvalho, Felix Dias
    [J]. CURRENT RESEARCH IN TOXICOLOGY, 2022, 3
  • [4] Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users
    Back-Madruga, C
    Boone, KB
    Chang, L
    Grob, CS
    Lee, A
    Nations, H
    Poland, RE
    [J]. CLINICAL NEUROPSYCHOLOGIST, 2003, 17 (04) : 446 - 459
  • [5] Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users
    Back-Madruga, C
    Boone, K
    Chang, L
    Grob, C
    Poland, R
    Lee, A
    Nations, H
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2003, 18 (07) : 720 - 720
  • [6] Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment
    Bhattachary, S
    Powell, JH
    [J]. PSYCHOLOGICAL MEDICINE, 2001, 31 (04) : 647 - 658
  • [7] The Agony of Ecstasy: MDMA (3,4-Methylenedioxymethamphetamine) and the Kidney
    Campbell, Garland A.
    Rosner, Mitchell H.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06): : 1852 - 1860
  • [8] NEUROCHEMISTRY AND NEUROTOXICITY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY)
    MCKENNA, DJ
    PEROUTKA, SJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 54 (01) : 14 - 22
  • [9] Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
    McCann, UD
    Slate, SO
    Ricaurte, GA
    [J]. DRUG SAFETY, 1996, 15 (02) : 107 - 115
  • [10] The cardiovascular effects of ecstasy (3,4-methylenedioxymethamphetamine, MDMA)
    Lester, SJ
    Baggott, MJ
    Viloria, EM
    Welm, S
    Schiller, NB
    Mendelson, J
    Jones, RT
    Foster, E
    [J]. CIRCULATION, 1999, 100 (18) : 575 - 575
12345